Improved antimicrobial susceptibility of community- acquired uropathogens in northern Israel (1995-1999-2002)

被引:4
作者
Chazan, B [1 ]
Sakran, W
Raz, R
Colodner, R
机构
[1] Ha Emek Med Ctr, Infect Dis Unit, IL-18101 Afula, Israel
[2] Ben Gurion Univ Negev, Ha Emek Med Ctr, Dept Family Med, No Branch, Afula, Israel
[3] Ha Emek Med Ctr, Microbiol Lab, IL-18101 Afula, Israel
[4] Technion Israel Inst Technol, Rappaport Sch Med, Haifa, Israel
关键词
susceptibility; community-acquired UTI; uropathogens; resistance; empirical treatment;
D O I
10.1016/j.ijantimicag.2004.01.007
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Since antimicrobial therapy for the treatment of community-acquired urinary tract infection is given empirically, knowledge of local antimicrobial sensitivity patterns is essential for clinicians. This study compares the susceptibility to antimicrobial drugs, of all urinary isolates from outpatients processed at the Ha 'Emek Medical Center during 1995, 1999 and 2002. No significant changes in the susceptibility to ceftriaxone and ciprofloxacin were seen over this period of time. There was a significant increase insusceptibility to amoxycillin-clavulanate, TMP-SXZ, cefuroxime and nitrofurantoin. MIC90 values of all drugs except amoxicillin-clavulanate remained stable. In contrast to a worldwide increase in resistance, we observed not only a halt in this trend, but also an improvement in antimicrobial susceptibility of uropathogens in northern-Israel. (C) 2004 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:89 / 92
页数:4
相关论文
共 11 条
[1]  
CLARRIDGE JE, 1998, LAB DIAGNOSIS URINAR
[2]   Antimicrobial susceptibility of community-acquired uropathogens in northern Israel [J].
Colodner, R ;
Keness, Y ;
Chazan, B ;
Raz, R .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (02) :189-192
[3]   Acute uncomplicated urinary tract infection in women [J].
Fihn, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (03) :259-266
[4]   Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in The Netherlands [J].
Goettsch, W ;
van Pelt, W ;
Nagelkerke, N ;
Hendrix, MGR ;
Buiting, AGM ;
Petit, PL ;
Sabbe, LJM ;
van Griethuysen, AJA ;
de Neeling, AJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (02) :223-228
[5]   Community acquired infections and bacterial resistance [J].
Goossens, H ;
Sprenger, MJW .
BRITISH MEDICAL JOURNAL, 1998, 317 (7159) :654-657
[6]   Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections [J].
Gupta, K ;
Hooton, TM ;
Stamm, WE .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (01) :41-50
[7]  
NCCLS, 2001, M100S11 NCCLS, pM100
[8]   Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens [J].
Raz, R ;
Chazan, B ;
Kennes, Y ;
Colodner, R ;
Rottensterich, E ;
Dan, M ;
Lavi, I ;
Stamm, W .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (09) :1165-1169
[9]   Changing use of antibiotics in community-based outpatient practice, 1991-1999 [J].
Steinman, MA ;
Gonzales, R ;
Linder, JA ;
Landefeld, CS .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (07) :525-533
[10]   Surveillance for antimicrobial resistance in Croatia [J].
Tambic Andrasevic, A ;
Tambic, T ;
Kalenic, S ;
Jankovic, V .
EMERGING INFECTIOUS DISEASES, 2002, 8 (01) :14-18